Unobtrusive Sensing of Medication Intake ("USE-MI")

Description

The purpose of this study is to test the USE-MI system hardware and software to see if it can accurately measure when subjects take their HIV-related medications and help them remember to take these medications. With the use of a smartwatch and smartphone "app", investigators hope to be able to monitor medication adherence in real-time and send subjects electronic reminders when they may have forgotten to take their medication.

Conditions

Medication Adherence

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to test the USE-MI system hardware and software to see if it can accurately measure when subjects take their HIV-related medications and help them remember to take these medications. With the use of a smartwatch and smartphone "app", investigators hope to be able to monitor medication adherence in real-time and send subjects electronic reminders when they may have forgotten to take their medication.

Unobtrusive Sensing of Medication Intake ("USE-MI")

Unobtrusive Sensing of Medication Intake ("USE-MI")

Condition
Medication Adherence
Intervention / Treatment

-

Contacts and Locations

Seattle

Swedish Medical Center, Seattle, Washington, United States, 98122

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Either a) have an HIV infection and are taking ART, or b) risk factors for contracting HIV infection and are taking PrEP
  • * Taking their medications from pill bottles, or other containers that the USE-MI system can monitor properly
  • * Reasonable proficiency in English
  • * Able to come to the research office for monthly follow-up visits
  • * Not responsible for taking their own HIV medications (e.g. residing in a supervised setting where their medications are administered to them)
  • * Taking medications using a method that the USE-MI system cannot monitor properly
  • * Lacking proficiency in English

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Swedish Medical Center,

Barry Saver, MD, PRINCIPAL_INVESTIGATOR, Swedish Medical Center

Jenna Marquard, PhD, PRINCIPAL_INVESTIGATOR, University of Massachusetts, Amherst

Study Record Dates

2025-12-31